William Dahut

A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.

W D Figg, William Dahut, Paul H. Duray et al. · PubMed · 2001 · 304 citations

Medicine, Pharmacology, Pharmacotherapy +13

A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer.

Pankaj Bhargava, John L. Marshall, Naiyer A. Rizvi et al. · PubMed · 1999 · 136 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

Chris H. Takimoto, Scot C. Remick, Sunil Sharma et al. · Journal of Clinical Oncology · 2003 · 121 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

A Phase I study of LGD1069 in adults with advanced cancer.

Naiyer A. Rizvi, John L. Marshall, William Dahut et al. · PubMed · 1999 · 104 citations

Medicine, Oncology, Pharmacology +17

A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.

Pankaj Bhargava, J L Marshall, William Dahut et al. · PubMed · 2001 · 81 citations

Medicine, Oncology, Pharmacology +17